Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Rough market day for Nektar, while Pharmacyclics and Regeneron soar
Rough market day for Nektar, while Pharmacyclics and Regeneron soar
Rough market day for Nektar, while Pharmacyclics and Regeneron soar
Submitted by
admin
on September 27, 2013 - 8:37am
Source:
Marketwatch
News Tags:
Nektar
Pharmacyclics
Regeneron
osteoarthritis
NKTR-181
ibrutinib
Headline:
Rough market day for Nektar, while Pharmacyclics and Regeneron soar
Do Not Allow Advertisers to Use My Personal information
